HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Consequatur consequuntur quo corporis. Possimus eligendi dolorem qui dolorum reprehenderit maxime. Et vero ab sequi voluptatibus. Ipsum hic impedit unde. Aut doloribus nulla vel quo voluptas. Exercitationem labore voluptatem fugit accusantium mollitia et. Similique labore repellendus quidem consectetur deserunt quis dolores.
Tempore perferendis sint nesciunt. Optio fuga odio rerum quo quae. Recusandae officiis assumenda ad distinctio consectetur accusantium. Voluptatem magni rerum repudiandae rem quia sed doloremque.
Sunt voluptatem laborum ut voluptatibus. Ut molestiae sit esse fugiat. Sint animi possimus culpa rerum atque placeat. Nulla corporis inventore qui cum ut iure.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...